How is ChronoScale (CHRN) planning to reach US$1 billion of run-rate revenue?

Sonal Goyal

28 October 2026 04:59 PM AEDT

How is ChronoScale (CHRN) planning to reach US$1 billion of run-rate revenue?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

First-quarter Revenue from continuing operations was US$41.5 million, up 148 per cent, attributed to a new customer buying AI infrastructure hardware under resale arrangements.
The company targets US$1 billion of annualised run-rate revenue by calendar third quarter 2027, a figure it says is neither a GAAP measure nor a forecast.
Two customers accounted for 56 per cent and 44 per cent of first-quarter revenue, and the filing reports a Working Capital Deficit of about US$70.5 million.

From exoskeletons to AI cloud

ChronoScale Holdings Corporation (NASDAQ:CHRN) is the public parent of an AI-focused Cloud Computing business. According to its quarterly filing, the legacy company, Ekso Bionics Holdings, Inc., completed a reverse Acquisition with Applied Digital Cloud Corporation on 5 May 2026 and was renamed ChronoScale Corporation. On 1 July 2026 a holding-company transaction made ChronoScale Holdings Corporation the public parent.

The legacy exoskeleton Business was sold on 30 September 2026. The company now provides cloud computing for AI, machine-learning and high-performance workloads on GPU infrastructure at third-party colocation facilities in the United States, and it is headquartered in Menlo Park, California. It is a separate company from Applied Digital Corporation, which provides ChronoScale with a grid note.

First-quarter results

On 15 October 2026, ChronoScale reported results for the fiscal first quarter ended 31 August 2026. Revenue from continuing operations was US$41.5 million, up 148 per cent from US$16.7 million, which the company attributed to a new customer buying AI infrastructure hardware under resale arrangements.

Net loss from continuing operations was US$26.4 million, or US$0.18 per share, compared with US$11.2 million a year earlier. Including a US$16.1 million loss from discontinued operations, the total net loss was US$42.5 million. Adjusted EBITDA, a non-GAAP measure, was US$5.9 million against US$9.4 million. Cost of revenues was US$45.6 million, above revenue, and selling, general and administrative expenses were US$20.7 million, largely stock-based compensation. Cost of revenues exceeded revenue by about US$4.1 million, a negative gross Margin of roughly 10 per cent, though the release does not break down which costs sit within that line.

The US$1 billion target

The only quantified outlook is a target of US$1 billion in annualised run-rate revenue by calendar third quarter 2027. The company defines run-rate revenue as quarterly revenue expected under contracts, multiplied by four, and states that it is neither a GAAP measure nor a forecast. No total contracted Backlog figure was disclosed.

Capacity announcements include a 50 MW North American deployment for Microsoft expected to use NVIDIA GB300 NVL72 systems, and a three-year Partnership with Baseten Labs for roughly 4 MW, with completion expected in the first calendar quarter of 2027. A partnership with Nutanix was also announced without a capacity figure.

Liquidity, concentration and risk

Cash was US$15.2 million at 31 August 2026, compared with US$9.7 million at 31 May. After quarter end the company received US$328.2 million of prepayments under customer contracts, though it warns that customers may be entitled to refunds in certain circumstances. Total liabilities were US$144.8 million against Equity of US$150.7 million, and the filing reports a working capital deficit of about US$70.5 million.

Management concluded that substantial doubt about Going Concern is alleviated, based on planned financing, collections and Capital Expenditure timing. Two customers accounted for 56 per cent and 44 per cent of first-quarter revenue, which is a very high concentration.

On 15 September 2026, the company drew US$8.0 million under its grid note from Applied Digital, leaving US$85.0 million of undrawn capacity, and Applied Digital agreed not to exercise its Demand right before 15 October 2027.

What to watch

Points to watch include evidence that contracts convert into run-rate revenue, the timing of power and equipment deliveries, the use of the customer prepayments, and whether margins turn positive. The next results date has not been confirmed.

FAQs

Q: What is ChronoScale's run-rate revenue target?

A: The company targets US$1 billion in annualised run-rate revenue by calendar third quarter 2027. It states that this is neither a GAAP measure nor a forecast.

Q: How did ChronoScale become an AI cloud company?

A: Ekso Bionics Holdings completed a reverse acquisition with Applied Digital Cloud Corporation on 5 May 2026 and was renamed ChronoScale. The legacy exoskeleton business was sold on 30 September 2026.

Q: What were ChronoScale's first-quarter results?

A: Revenue from continuing operations was US$41.5 million, up 148 per cent, and the total net loss was US$42.5 million. Cash was US$15.2 million at 31 August 2026.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.